Validation of Texture Changing Coatings for Use in At-Home Rapid Tests
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age12+
SponsorUniversity of Delaware
About this trial
At-home testing is an important part of mitigating the spread of COVID-19, but these tests are not accessible to people with low vision or blindness. Instead of adapting to a technology originally built for sighted people, investigators propose a no-power version that reports test results through a texture change, which people can feel by touch. This platform could be used not only for COVID, but also for other diagnostics, and will promote the independence and privacy for people with low vision or blindness by removing the need for human assistance or an internet connection.
Eligibility criteria
Qualifiers
Visual Impairment: Participants should be blind or visually impaired for greater than 10 years, either congenitally or acquired.
Tactile Aid Usage: Participants must use tactile aids regularly.
Mathematical Knowledge: Participants should have a basic understanding of mathematical plots, equivalent to at least high school geometry.
Disqualifiers
Limb Conditions: Participants with amputations or outer extremity conditions affecting hand use will be excluded.
Trial design
Treatments tested in this trial
- Interaction with Mock COVID-19 Rapid Antigen Test and Reference Surfaces
- Biomechanical Measurements
- Psychophysical Tasks
Treatment groups
20 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov